Semax
Peptide therapy: benefits, side effects, cost and protocols
Semax is a synthetic heptapeptide nootropic developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is used in Eastern Europe for brain trauma treatment and for its claimed neuroprotective, nootropic, and neurorestorative effects.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- FDA status
- Banned from Compounding March 2024 Not eligible for compounding. Synthetic ACTH fragment not approved for human use in the US.
- Evidence
- Strong Evidence
Who it's for
Who Semax is usually considered for
- Cognitive enhancement
- Neuroprotection
- Memory improvement
- Focus
- Phase 4
Mechanism
How Semax works
ACTH (4-10) analog that may enhance BDNF levels and modulate neurotransmitter systems without hormonal effects.
Evidence
Key studies
232 papers on PubMed / 52 human trials
- 01
[Results of the application of complex physiotherapeutic neurostimulation in optical neuropathies of various genesis]
- 02
Dragon AK, Korchazhkina NB, Sheludchenko VM et al
Vopr Kurortol Fizioter Lech Fiz Kult / Vopr Kurortol Fizioter Lech Fiz Kult / RCT
Complex neurostimulation with Semax achieved 83-94% efficacy in improving visual field and light sensitivity in vascular optic neuropathy.
- 03
Complex neurostimulation with Semax achieved 83-94% efficacy in improving visual field and light sensitivity in vascular optic neuropathy
- 04
Functional Connectomic Approach to Studying Selank and Semax Effects
- 05
Panikratova YR, Lebedeva IS, Sokolov OY et al
Dokl Biol Sci / Dokl Biol Sci / RCT
- 06
Selank and Semax produce distinct functional connectivity changes in amygdala and prefrontal regions
- 07
Effects of Semax on the Default Mode Network of the Brain
- 08
Lebedeva IS, Panikratova YR, Sokolov OY et al
Bull Exp Biol Med / Bull Exp Biol Med / RCT
- 09
Semax increased default mode network volume in medial frontal cortex compared to placebo on fMRI
- 10
Sigmoidal maximal effect modeling of low-density lipoprotein cholesterol concentration and annual incidence of coronary heart disease events in secondary prevention trials
Pharmacotherapy
Compound
Semax compound data
- Formula
- C37H51N9O10S
- Mol. weight
- 813.9 g/mol
- PubChem CID
- 9811102 ↗
- IUPAC
- (2S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanyl-butanoyl]amino]-4-carboxy-butanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenyl-propanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid
FAQ
Semax questions
What is SEMAX?
Semax is a synthetic peptide based on ACTH (adrenocorticotropic hormone) fragment, developed in Russia and extensively researched for cognitive enhancement and neuroprotection.
How does SEMAX work?
ACTH (4-10) analog that may enhance BDNF levels and modulate neurotransmitter systems without hormonal effects.
Is SEMAX legal to buy?
SEMAX is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy SEMAX?
SEMAX is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.
What category does SEMAX belong to?
SEMAX is primarily classified as a cognitive enhancement peptide. Nootropic peptides researched for cognitive function, memory, focus, neuroprotection, and neurogenesis.
What are the research benefits of SEMAX?
SEMAX has been studied for: Cognitive enhancement, Neuroprotection, Memory improvement, Focus. ACTH analog; established nootropic peptide.
News
Semax in the news
The Brain Is the Next Frontier for Unregulated Peptides - Bloomberg.com
Bloomberg.com / 2 days ago
Brain peptides? People trying unapproved substances for sharper focus - NewsNation
NewsNation / 1 day ago
FDA advisory panel recommends peptide Semax be added to pharmacy compounding list - Reuters
Reuters / 2 months ago
The Brain Is the Next Frontier for Unregulated Peptides - The Business of Fashion
The Business of Fashion / 2 days ago
Peptide Safety and Cancer Risk: What You Need to Know - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute / 2 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Considering Semax?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.